I am a breastfeeding mother and i want to know if it is safe to use UNII-4AF302ESOS? Is UNII-4AF302ESOS safe for nursing mother and child? Does UNII-4AF302ESOS extracts into breast milk? Does UNII-4AF302ESOS has any long term or short term side effects on infants? Can UNII-4AF302ESOS influence milk supply or can UNII-4AF302ESOS decrease milk supply in lactating mothers?
- DrLact safety Score for UNII-4AF302ESOS is 1 out of 8 which is considered Safe as per our analyses.
- A safety Score of 1 indicates that usage of UNII-4AF302ESOS is mostly safe during lactation for breastfed baby.
- Our study of different scientific research also indicates that UNII-4AF302ESOS does not cause any serious side effects in breastfeeding mothers.
- Most of scientific studies and research papers declaring usage of UNII-4AF302ESOS safe in breastfeeding are based on normal dosage and may not hold true for higher dosage.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
A receptor-antagonist 5HT3 serotonin-type antiemetic drug that is used for treatment of nausea and vomiting.Usage is authorized for children older than 6 months. It has been used in one-month-old infants. At latest update no published data were found on excretion into breast milk. Since it is widely used during pregnancy and in young children without occurrence of side effects, its use is considered compatible while breastfeeding.
Little published information is available on the clinical use of UNII-4AF302ESOS during breastfeeding, although it is apparently frequently used for nausea after cesarean section, usually in doses of 4 to 8 mg intravenously. Use after cesarean section appears to not affect the onset of breastfeeding. No adverse infant effects have been reported and the drug has been used in infants. If UNII-4AF302ESOS is required by the mother, it is not a reason to discontinue breastfeeding; however an alternate drug may be preferred, especially while nursing a newborn or preterm infant.
A randomized, double-blind study compared placebo to intravenous UNII-4AF302ESOS 4 mg given after cesarean section as prophylaxis for postoperative nausea and vomiting. There was no difference in the time of the first breastfeeding between the two groups.
: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.